MedTrace Logo

Wound Edge Changes Following Treatment With Santyl

NCT01197898 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2013-05-30

Study results available
· View outcomes & findings →

Summary

The goal of this study is to evaluate changes in the healing tissue of diabetic foot wounds following 14 days of treatment with Santyl or its vehicle base.

Conditions

  • Diabetic Foot Ulcers
  • Diabetic Foot Wounds

Interventions

BIOLOGICAL

Collagenase Santyl Ointment

Topical daily application

OTHER

Placebo Comparator

Topical daily application

Sponsors & Collaborators

  • Healthpoint

    lead INDUSTRY

Principal Investigators

  • Herbert B Slade, MD · Healthpoint

  • Art J Tallis, DPM · Associated Foot & Ankle Specialists

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-12-31
Primary Completion
2012-04-30
Completion
2012-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01197898 on ClinicalTrials.gov